Böbreğin Benign Tümörleri

Amin MB, Gill AJ, Hartmann A, et al. WHO Classification of tumours editorial board, WHO Classification of Tumours Urinary and Male Genital Tumors (5th Edition. Vol 8) içinde. LYON: WHO Press; 2022.p.2-3,31
Martignoni G, Pea M, Zampini C, et al. PEComas of the kidney and of the genitourinary tract. Seminars Diagnostic Pathology. 2015 Mar;32(2):140-59. doi: 10.1053/j.semdp.2015.02.006. Epub 2015 Feb 24. PMID: 25804448.
Çalışkan S, Gümrükçü G, Özsoy E, et al. Renal angiomyolipoma. Revista da Associação Médica Brasileira. 2019 Aug 5;65(7):977-981. doi: 10.1590/1806-9282.65.7.977. PMID: 31389508.
Bhatt JR, Richard PO, Kim NS, et al. Natural History of Renal Angiomyolipoma (AML): Most Patients with Large AMLs >4cm Can Be Offered Active Surveillance as an Initial Management Strategy. Europen Urology. 2016 Jul;70(1):85-90. doi: 10.1016/j.eururo.2016.01.048. Epub 2016 Feb 9. PMID: 26873836.
Bouaziz H, Ghalleb M, Tounsi N, et al. A renal angiomyolipoma with a challenging presentation: a case report. Journal of Medical Case Reports. 2021 Sep 27;15(1):477. doi: 10.1186/s13256-021-03073-0. PMID: 34565446; PMCID: PMC8474819.
Schieda N, Kielar AZ, Al Dandan O, et al. Ten uncommon and unusual variants of renal angiomyolipoma (AML): radiologic-pathologic correlation. Clinical Radiology. 2015 Feb;70(2):206-20. doi: 10.1016/j.crad.2014.10.001. Epub 2014 Nov 15. PMID: 25468637.
Flum AS, Hamoui N, Said MA, et al. Update on the Diagnosis and Management of Renal Angiomyolipoma. Journal Of Urological Surgery. 2016 Apr;195(4 Pt 1):834-46. doi: 10.1016/j.juro.2015.07.126. Epub 2015 Nov 21. PMID: 26612197.
Umbreit EC, Thompson RH. Metastatic potential of the small renal mass: why can't we agree? Europen Urology. 2011 Nov;60(5):983-5; discussion 985-6. doi: 10.1016/j.eururo.2011.07.004. Epub 2011 Jul 12. PMID: 21783319.
Wang KL, Weinrach DM, et al. Renal papillary adenoma--a putative precursor of papillary renal cell carcinoma. Human Pathology. 2007 Feb;38(2):239-46. doi: 10.1016/j.humpath.2006.07.016. Epub 2006 Oct 23. PMID: 17056094.
Caliò A, Warfel KA, Eble JN. Papillary Adenomas and Other Small Epithelial Tumors in the Kidney: An Autopsy Study. The American Journal of Surgical Pathology. 2019 Feb;43(2):277-287. doi: 10.1097/PAS.0000000000001189. PMID: 30418186.
Hartmann A, Cheville J, HesO, Kuroda N, Rioux-Leclercq NC, Renal Papillary Adenoma WHO Classification of tumours editorial board, WHO Classification of Tumours Urinary and Male Genital Tumors (5th Edition. Vol 8) içinde. LYON: WHO Press; 2022.p.45-46
Umbreit EC, Thompson RH. Metastatic potential of the small renal mass: why can't we agree? Europen Urology. 2011 Nov;60(5):983-5; discussion 985-6. doi: 10.1016/j.eururo.2011.07.004. Epub 2011 Jul 12. PMID: 21783319.
Chang HY, Hang JF, Wu CY, et al. Clinicopathological and molecular characterisation of papillary renal neoplasm with reverse polarity and its renal papillary adenoma analogue. Histopathology. 2021 Jun;78(7):1019-1031. doi: 10.1111/his.14320. Epub 2021 Apr 10. PMID: 33351968.
Abdessater M, Kanbar A, Comperat E, et al. Renal Oncocytoma: An Algorithm for Diagnosis and Management. Urology. 2020 Sep;143:173-180. doi: 10.1016/j.urology.2020.05.047. Epub 2020 Jun 5. PMID: 32512107.
Ng KL, Morais C, Bernard A, et al. A systematic review and meta-analysis of immunohistochemical biomarkers that differentiate chromophobe renal cell carcinoma from renal oncocytoma. Journal of Clinical Pathology. 2016 Aug;69(8):661-71. doi: 10.1136/jclinpath-2015-203585. Epub 2016 Mar 7. PMID: 26951082.
Wobker SE, Williamson SR. Modern Pathologic Diagnosis of Renal Oncocytoma. Journal of Kidney Cancer and VHL. 2017 Oct 9;4(4):1-12. doi: 10.15586/jkcvhl.2017.96. PMID: 29090117; PMCID: PMC5634396.
Hartmann A, Gill AJ, He HY, Kry ven ko ON, Ohashi R, Tretiakova MS. WHO Classification of tumours editorial board, WHO Classification of Tumours Urinary and Male Genital Tumors (5th Edition. Vol 8) içinde. LYON: WHO Press; 2022.p.50-52
Mirkheshti N, Farrukh N, Legesse T, et al. Renal oncocytoma: a challenging diagnosis. Current Opinion in Oncology. 2022 May 1;34(3):243-252. doi: 10.1097/CCO.0000000000000829. PMID: 35671122.
Rodríguez-Zarco E, Machuca-Aguado J, Macías-García L, et al. Metanephric adenoma: molecular study and review of the literature. Oncotarget. 2022 Feb 17;13:387-392. doi: 10.18632/oncotarget.28192. PMID: 35198098; PMCID: PMC8852360.
Kinney SN, Eble JN, Hes O, et al. Metanephric adenoma: the utility of immunohistochemical and cytogenetic analyses in differential diagnosis, including solid variant papillary renal cell carcinoma and epithelial-predominant nephroblastoma. Modern Pathology. 2015 Sep;28(9):1236-48. doi: 10.1038/modpathol.2015.81. Epub 2015 Aug 7. PMID: 26248896.
Benson M, Lee S, Bhattacharya R, et al. Metanephric Adenoma in the Pediatric Population: Diagnostic Challenges and Follow-up. Urology. 2018 Oct;120:211-215. doi: 10.1016/j.urology.2018.06.042. Epub 2018 Jul 10. PMID: 30006267.
Zhang W, Song Y, Cui H, et al. Metanephric adenoma of the kidney: A case report and literature review. Asian Journal of Surgery. 2022 Dec 19:S1015-9584(22)01740-7. doi: 10.1016/j.asjsur.2022.12.030. Epub ahead of print. PMID: 36543673.